Agetech

Epigenetic reprogramming: the road to reversing time

Epigenetic modifications – also known as “aging clocks” – have emerged as promising markers of aging and accurate predictors of age-related diseases; they're a hot...

Primetime Partners get ready for Longevity primetime

New VC firm seeks start-ups who are working to solve the “urgent problems” facing today’s aging society. This summer, a new venture capital firm was...

Cartilage regrowth could be Longevity OA gamechanger

Stanford team regenerate cartilage in joints using chemical triggers. Cartilage is the smooth white tissue that covers the ends of bones, supporting them and protecting...

Longevity interventions: find out what’s working – and what isn’t

Data-BETA Project proposes wide-ranging human study of anti-aging interventions to find out what combinations are delivering real benefits. Recent developments in methylation clocks have convinced...

Biofourmis raises $100M to scale digital therapeutics

Health start-up Biofourmis, which leverages AI for personalised healthcare monitoring, has raised $100m from SoftBank. SoftBank Group has led a $100m investment in Biofourmis, the...

Leading academic sees “great promise” in longevity supplements

Buck professor Brian Kennedy talks about AKG and the potential for supplements to deliver real anti-aging benefits. Following Tuesday’s news from the Buck Institute about...

Nuritas claims world’s first AI-discovered anti-inflammatory

Nuritas does it rice and easy with peer-reviewed publication revealing natural peptides that reduce inflammation. Nuritas, a Dublin-based company that boasts U2’s Bono and The...

AKG study first to show “dramatically compressed” morbidity in mammals

The Buck's new peer-reviewed study of alpha-ketoglutarate shows a significant reduction in frailty in older mice, resulting in compression of late-life morbidity. The Buck Institute...

Healthy aging – it’s still all about diet and exercise. For now

As Healthy Aging Month arrives, Dr Thomas Rando shares his views on progress in Longevity science. For the past two decades, September has been celebrated...

Elysium publishes positive results from two studies for Basis

Encouraging news from Elysium Health illustrates that the Longevity supplements market is building clinical and commercial traction. In December 2019, Elysium announced a $40m Series...

Insurance and home modifications key to independent living

While they may not be the most exciting factors to consider as we enter later life, choosing the right health insurance and making home...

Taking NAD+ to the next level

Nuchido’s systems pharmacology approach yields NAD+ supplement that claims to boost levels by 242%!    A new player in the NAD+ supplement market has arrived...

AgeTech investment: “there is everything to play for”

AgeTech Accelerator's Lorraine Morley on market disconnect, helping investors take the plunge and shaping the AgeTech market. Continuing our series of interviews with our Advisory Panel...

Targeting multiple Longevity biomarkers in a single panel

Jinfiniti raising $5m as it prepares to launch new biomarkers test panel that measures genomic instability, epigenetic alteration, inflammation, cellular senescence, oxidative stress, tissue...

Juvenescence (2): “It’s all about prevention, and that’s incredibly disruptive”

Juvenescence's Greg Bailey on democratising healthcare, paradigm shifts and disruptive technologies. Yesterday we published the first part of our interview with Greg Bailey, CEO of...

Juvenescence (1): from strength to strength in R&D and investment firepower

Juvenescence's Greg Bailey on transformative scientific opportunities, immuno-resilience, modifying aging and funding. Continuing our series of interviews with our Advisory Panel members, we spoke to Greg...

Selfie biomarkers: AI and insurtech implications for Longevity

AI firm Lapetus targets the face as a biomarker of aging: one simple picture can open-up a host of opportunities and implications. Wow. Named after...

Longevity opportunities in the post-Covid world

Longevity International’s Tina Woods discusses how Covid-19 has catapulted health to the top of the global agenda. Tina Woods is CEO and co-founder of Longevity...

Study of twins reveals longitudinal DNA methylation information

A decade-long study has made interesting contributions to the study of the stability of DNA methylation. A study of epigenetic changes in identical twins by...

Tonus seeks early-stage funding for exoskeleton tech

Company spawned by London start-up generator targets middle-aged recreational athletes with exoskeleton leggings powered by soft robotics. Back in November, we brought you the story...

Latest articles

At-home wellness biomarker test to deliver instant results

ZiO Health prepares to launch crowdfunding campaign for subscription-based urine test that measures multiple health biomarkers. Biomedical start-up ZiO Health is on a mission to...

Inflammaging biotech acquired by Roche for €380m

One of the largest deals in Irish biotech history sees Roche gain rights to full Inflazome portfolio. The Swiss company Roche has bought Dublin-based biotech...

AI app reveals your biological age – and how to slow it down

Only as old as you feel ... or only as old as your Young.AI app tells you? We use our phones for just about everything...

Psychobiome: trusting your gut for Longevity

Scientists studying how the microbiome affects our mood aim to develop gut microbiome-modulating formulations to treat depression and other brain diseases. Recent work from Katya...